MARYLAND AG SECURES $15 MILLION RECOVERY FROM GLAXOSMITHKLINE

(The following is a reformatted version of a press release
issued by the Office of Maryland Attorney General Douglas F.
Gansler and received via electronic mail. The release was
confirmed by the sender.) 
AG Gansler Secures $15 Million Recovery From GlaxoSmithKline
Company misled state health care programs, consumers about popular
diabetes drugs Avandia, Avandamet and Avandaryl 
Prescription medications dramatically increase risk of heart attack
Baltimore, MD (December 17, 2013) - Attorney General Douglas F. Gansler today 
announced the state has recovered $15 million from GlaxoSmithKline, LLC,  
resolving allegations that the company engaged in improper marketing of the 
prescription drugs Avandia, Avandamet and Avandaryl, all of which are used to 
treat diabetes. The settlement is the result of a lawsuit filed last February 
by the Office of the Attorney General against GlaxoSmithKline in Baltimore City 
Circuit Court. 
"The distorted promotion of these drugs put diabetes patients at serious risk 
by misrepresenting the facts concerning their safety and usefulness," said 
Attorney General Gansler. "Consumers should know the whole truth about the 
medications they get and taxpayers shouldn't have to pay the cost for such 
behavior by the drug maker." 
The lawsuit, filed under the Maryland False Health Claims Act and other legal 
theories, alleged that GlaxoSmithKline touted the drugs as superior to other 
diabetes medications even though they were not, in fact, better at treating the 
disease. The lawsuit also alleged that the company withheld data showing that 
its three drugs dramatically increase a patient's chances of suffering a heart 
attack or other serious adverse events. The lawsuit further alleged that 
despite its knowledge of these risks, GlaxoSmithKline promoted the drug as safe 
for use. 
The state purchased Avandia and the other drugs through the Employee 
Prescription Drug Plan, the State Retiree Prescription Drug Plan, the Medical 
Assistance Program and other state health care programs. 
To see the settlement agreement visit: 
http://www.oag.state.md.us/Press/Executed_Settlement_Agreement.pdf 
For a redacted version of the complaint filed under seal by order of the court 
visit:
http://www.oag.state.md.us/Press/Avandia_complaint_2013_02_20.pdf 
(rml) NY
 
 
Press spacebar to pause and continue. Press esc to stop.